Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on December 11, 2003

Stroke. 2003
Published online before print December 11, 2003, doi: 10.1161/01.STR.0000106160.34316.19
A more recent version of this article appeared on January 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/1/205    most recent
01.STR.0000106160.34316.19v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broderick, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broderick, J. P.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Emergency treatment of Stroke
Right arrow Genetics of Stroke
Right arrow Primary and Secondary Stroke Prevention
Right arrow Rehabilitation, Stroke
Right arrow Thrombolysis
Right arrow Epidemiology

Submitted on August 27, 2003
Accepted on September 10, 2003

William M. Feinberg Lecture: Stroke Therapy in the Year 2025. Burden, Breakthroughs, and Barriers to Progress

Joseph P. Broderick MD*

From the Division of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio.

* To whom correspondence should be addressed. E-mail: joseph.broderick{at}uc.edu.

Background--More than 700 000 strokes occurred in the United States during 2002, of which approximately 500 000 are first-ever strokes and 200 000 recurrent strokes. If we would decrease the enormous burden of stroke throughout the world, we first need to know the barriers that we have to overcome. These are quite similar to the barriers that we have tried to surmount during the last 25 years.

Stroke Prevention--We have developed many successful primary and secondary therapies to prevent stroke over the past 25 years and have begun to understand some of the genetic risk factors underlying stroke. Yet, the incidence rate of stroke in Rochester, Minn, remained unchanged from 1975 to the mid-1990s, and mortality rates for Ohio have changed little for men, women, blacks, and whites over the past decade. The primary reason that we have made little progress in decreasing the burden of stroke is that we have made little progress in modifying the primary risk factors for stroke in the population. Other barriers of improved stroke prevention in the future include costs of therapy and aging of blood vessels and brain, which is the most important risk factor for stroke.

Acute Stroke--Breakthroughs in acute stroke treatment are likely to follow the steps of cardiology with the primary focus for ischemic stroke on the restoration of oxygenated blood flow to ischemic brain as quickly as possible. To improve acute stroke therapy in the year 2025, we need to have more focused messages sent to the lay public about stroke warning signs, better and safer methods to open arteries quickly, truly effective neuroprotection in the setting of reperfusion, regional organization for acute stroke therapy, and large randomized trials to find clinically important but smaller benefits. A scientifically proven treatment for treatment of acute intracerebral hemorrhage is another major goal.

Recovery After Stroke--Brain recovery after stroke is the area of scientific discovery with the largest potential for advances far into the next century. Obstacles that block effective therapies in the recovery from stroke include the extent of initial injury from stroke, the brain plasticity of a given patient, and, most importantly, understanding the "neural code"--how the brain is organized and how cells communicate with one another.


Key words: genetics • incidence • risk factors • stroke, acute • stroke prevention




This article has been cited by other articles:


Home page
StrokeHome page
S. T. Carmichael
Themes and Strategies for Studying the Biology of Stroke Recovery in the Poststroke Epoch
Stroke, April 1, 2008; 39(4): 1380 - 1388.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Andre, C. C. Curioni, C. Braga da Cunha, and R. Veras
Progressive Decline in Stroke Mortality in Brazil From 1980 to 1982, 1990 to 1992, and 2000 to 2002
Stroke, November 1, 2006; 37(11): 2784 - 2789.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Xie, E. Q. Wu, Z.-J. Zheng, J. B. Croft, K. J. Greenlund, G. A. Mensah, and D. R. Labarthe
Impact of Stroke on Health-Related Quality of Life in the Noninstitutionalized Population in the United States
Stroke, October 1, 2006; 37(10): 2567 - 2572.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Kleindorfer, J. Broderick, J. Khoury, M. Flaherty, D. Woo, K. Alwell, C. J. Moomaw, A. Schneider, R. Miller, R. Shukla, et al.
The Unchanging Incidence and Case-Fatality of Stroke in the 1990s: A Population-Based Study
Stroke, October 1, 2006; 37(10): 2473 - 2478.
[Abstract] [Full Text] [PDF]